Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

6 mins

Fiona Mosgrove: IPCRG COVID-19 and Respiratory Q&A – a Focus on COVID-19

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 6th 2022

touchRESPIRATORY caught up with Dr Fiona Mosgrove (University of Aberdeen Medical School, Aberdeen, Scotland) to discuss the COVID-19 and respiratory Q&A created by IPCRG and to answer some of the key questions around the variants of SARS-CoV-2, treatments for COVID-19 and what will happen as we move out of the pandemic.

Questions

  1. Could you give us a brief overview of the COVID-19 and respiratory Q&A that is available on the IPCRG website? (0:21)
  2. How do major symptoms vary for different variants of SARS-CoV-2? (1:13)
  3. What is known about the SARS-CoV-2 Omicron variant on asthma symptoms? (2:26)
  4. What oral drugs are effective against COVID-19? (3:39)
  5. What does the evidence suggest will happen with COVID-19 as we move out of the pandemic? (4:45)

Disclosures: Fiona Mosgrove has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

To find out more visit the website here.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup